Aberdeen Group plc boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 43.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 324,905 shares of the medical equipment provider's stock after buying an additional 97,721 shares during the quarter. Aberdeen Group plc owned 0.09% of Intuitive Surgical worth $158,760,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of ISRG. Castleark Management LLC lifted its position in Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after acquiring an additional 2,990 shares during the last quarter. Arlington Trust Co LLC lifted its stake in shares of Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after acquiring an additional 191 shares during the period. Aveo Capital Partners LLC boosted its holdings in Intuitive Surgical by 37.4% in the 1st quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider's stock valued at $390,000 after purchasing an additional 198 shares in the last quarter. Aaron Wealth Advisors LLC grew its holdings in Intuitive Surgical by 3.2% during the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after acquiring an additional 78 shares during the period. Finally, Longbow Finance SA grew its stake in shares of Intuitive Surgical by 132.0% during the 1st quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock worth $9,756,000 after purchasing an additional 11,209 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
ISRG has been the subject of several research analyst reports. Piper Sandler reaffirmed an "overweight" rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Evercore ISI upped their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Robert W. Baird lowered their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. UBS Group upped their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. Finally, Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $595.95.
Get Our Latest Research Report on ISRG
Intuitive Surgical Stock Performance
Shares of NASDAQ ISRG traded up $3.18 during midday trading on Friday, hitting $480.26. The company's stock had a trading volume of 1,436,064 shares, compared to its average volume of 2,169,233. The firm's fifty day moving average price is $508.75 and its 200-day moving average price is $524.77. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm has a market cap of $172.16 billion, a P/E ratio of 66.98, a P/E/G ratio of 5.03 and a beta of 1.59.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the company posted $1.78 earnings per share. The company's revenue for the quarter was up 21.4% compared to the same quarter last year. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Insider Activity at Intuitive Surgical
In related news, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 2,800 shares of the business's stock in a transaction on Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the completion of the sale, the insider directly owned 18,520 shares in the company, valued at $9,171,844.80. This represents a 13.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,839 shares of company stock worth $7,896,972 in the last three months. 0.70% of the stock is owned by company insiders.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.